Pyzchiva 130 mg, Konzentrat zur Herstellung einer Infusionslösung
7680699850013
CH-69985
Konzentrat
Associated product:
PYZCHIVA conc perf 130 mg 1 pce
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Konzentrat
- Galenic group
- Tinkturen/Desinfektion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
ustekinumabum
|
130.0 MG | Substance | Wirkstoff (Principe actif) |
|
histidinum
|
- | Substance | HNIDK |
|
histidini hydrochloridum monohydricum
|
- | Substance | HNIDK |
|
methioninum
|
- | Substance | HNIDK |
|
dinatrii edetas
|
- | Substance | HNIDK |
|
polysorbatum 80
|
- | Substance | HNIDK |
|
saccharum
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrium
|
0.066 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 1540.15
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/05/2026
Authorization holder
Samsung Bioepis CH GmbH
6005 Luzern
Authorization information
- Swissmedic authorization number
- 69985
- Drug name
- Pyzchiva, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L04AC05
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 21/03/2025
- Authorization expiration date
- 20/03/2030
- IT Number
- 07.15.0.
- Domain
- Human medicine
Package details
- Description (FR)
- PYZCHIVA conc perf 130 mg 1 pce
- Description (DE)
- PYZCHIVA Konz Inf 130 mg 1 Stk
- Market launch
- 20/04/2026
- Narcotic (BTM)
- No